Shreya Rx, Inc

Community/Retail Pharmacy



  
  200 Oriskany Blvd, Yorkville
New York, 13495-1330

 315-768-3347   
Shreya Rx, Inc is a Community/Retail Pharmacy in Yorkville, New York. It is located at 200 Oriskany Blvd, Yorkville and it's customer support contact number is 315-768-3347. The authorized person of Shreya Rx, Inc is Bhupen Patel who is Owner of the pharmacy and his contact number is 315-768-3347. Shreya Rx, Inc accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
Shreya Rx, Inc is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes.


Pharmacy Details:
Shreya Rx, Inc type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
Name: Shreya Rx, Inc
Type: Community/Retail Pharmacy
Location:200 Oriskany Blvd, Yorkville,
New York, 13495-1330
Phone:315-768-3347
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
Name: Bhupen Patel
Position: Owner
Contact Number: 315-768-3347
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
NPI Number: 1427211929
NPI Enumeration Date: 03 Jul, 2008
NPI Last Update On: 30 Dec, 2008

Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Shreya Rx, Inc are as mentioned below.
SpecializationLicense NumberStateStatus
Community/Retail Pharmacy Primary
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
IdentifierTypeStateIssuer
03053192MedicaidNew York
3358353OtherNew YorkNcpdp
Medicare Enrollment:
Shreya Rx, Inc is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
PAC ID: Enrollment ID: Org NameMedicare Entity Type
0749333466O20100930086689Shreya Rx, IncDME SUPPLIER - PHARMACY
Products Available:
Shreya Rx, Inc has following products available for sale under medicare.
Products:
•  Blood Glucose Monitors & Supplies: Non-mail Order•  Canes & Crutches
•  Commodes, Urinals, & Bedpans•  Cpap, Rads, & Related Supplies & Accessories
•  Diabetic Shoes & Inserts: Prefabricated•  Enteral Equipment And/or Supplies
•  Enteral Nutrients•  Heat & Cold Applications
•  Nebulizer Equipment & Supplies•  Orthoses: Off-the-shelf
•  Ostomy Supplies•  Parenteral Equipment And/or Supplies
•  Parenteral Nutrients•  Surgical Dressings
•  Urological Supplies•  Walkers
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 200 Oriskany Blvd,
Yorkville, New York
Zip: 13495-1330
Phone Number: --
Patients can reach Shreya Rx, Inc at 200 Oriskany Blvd, Yorkville, New York or can call on customer care at 315-768-3347.
Comments/ Reviews:
Read all the reviews posted for Shreya Rx, Inc below. You may also share your own experience with Shreya Rx, Inc. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.